CVR: 43131761
Secondary names: Beau Sejour ApS
DKK 246,808
Gross profit
Net result: DKK 95,817
Esrum Biotech Holding ApS
CVR · view ownership and management
Owner registered: Esrum Biotech Holding ApS
CVR · 25/04/2024
View the full event history
Esrum Biotech ApS is a Danish company of the type Anpartsselskab based in Fredensborg, founded in 2022. The company is registered under the industry Anden teknisk rådgivning. The management consists of Mette Kirstine Agger. The company is owned by Esrum Biotech Holding ApS. In 2025, the company reported a gross profit of DKK 246,808 and a net result of DKK 95,817 compared with DKK 1,202,026 the year before. Equity in the 2025 report amounted to DKK 135,817.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Source: annual reports filed with the Danish Business Authority.
Compared to 1.487 companies in Anden teknisk rådgivning
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEsrum Biotech ApS was founded on 15 March 2022.
Esrum Biotech ApS is registered under the industry Anden teknisk rådgivning (industry code 711290).
Esrum Biotech ApS is owned by Esrum Biotech Holding ApS.
In 2025, Esrum Biotech ApS reported a gross profit of DKK 246,808.
The management of Esrum Biotech ApS consists of Mette Kirstine Agger.
Esrum Biotech ApS is located at Søparken 7, 3480 Fredensborg.
Claim this page to add your logo and social links. Free to get started.
Esrum Biotech ApS has published its annual report for 2025. Gross profit came to DKK 246,808, and the net result was DKK 95,817.
Esrum Biotech ApS has published its annual report for 2024. Gross profit came to DKK 1,762,824, and the net result was DKK 1,202,026.
As of April 25, 2024, Esrum Biotech Holding ApS is registered as an owner of Esrum Biotech ApS with an ownership share of 100%.
Esrum Biotech ApS has published its annual report for 2023. Gross profit came to DKK 2,008,743, and the net result was DKK 1,458,238.
Esrum Biotech ApS has published its interim report for the period March 15, 2022 – December 31, 2022.
As of March 15, 2022, Mette Kirstine Agger is registered as director of Esrum Biotech ApS.
Esrum Biotech ApS was founded on March 15, 2022.
Companies in the same industry and area
CVR 25066863
CVR 18289482
CVR 10964571
CVR 46723341
CVR 40513388
